Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments

Peptide receptor radionuclide therapy (PRRT) has been shown to be an effective treatment for neuroendocrine tumors (NETs) if curative surgery is not an option. A majority of NETs abundantly express somatostatin receptors. Consequently, following administration of somatostatin (SST) analogs labeled w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bison, Sander M., Konijnenberg, Mark W., Melis, Marleen, Pool, Stefan E., Bernsen, Monique R., Teunissen, Jaap J. M., Kwekkeboom, Dik J., de Jong, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991004/
https://www.ncbi.nlm.nih.gov/pubmed/24765618
http://dx.doi.org/10.1007/s40336-014-0054-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991004/
https://www.ncbi.nlm.nih.gov/pubmed/24765618
http://dx.doi.org/10.1007/s40336-014-0054-2

Ejemplares similares